Cargando…
Medulloblastoma: advances and challenges
Medulloblastoma, a cancer of the posterior fossa, is the most common malignant brain tumor in children. Although 80% of patients with average-risk medulloblastoma are cured, their quality of life is often compromised by treatment-related side effects. Recently, molecular and genomic studies have sho...
Autores principales: | Roussel, Martine F., Robinson, Giles |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Faculty of 1000 Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3100785/ https://www.ncbi.nlm.nih.gov/pubmed/21655335 http://dx.doi.org/10.3410/B3-5 |
Ejemplares similares
-
Epigenetic Drivers in Pediatric Medulloblastoma
por: Roussel, Martine F., et al.
Publicado: (2017) -
Modeling pediatric medulloblastoma
por: Roussel, Martine F., et al.
Publicado: (2019) -
Preclinical Models of Craniospinal Irradiation for Medulloblastoma
por: Stripay, Jennifer L., et al.
Publicado: (2020) -
Combination of Ribociclib and Gemcitabine for the Treatment of Medulloblastoma
por: Pribnow, Allison, et al.
Publicado: (2022) -
Targeting protein folding in N‐Myc‐driven medulloblastoma
por: Valinciute, Gintvile, et al.
Publicado: (2023)